The Google News Initiative on Tuesday launched a global open fund to fight misinformation about COVID-19 vaccines, worth up to $3 million.
For more coronavirus news, visit our dedicated page.
The “COVID-19 Vaccine Counter Misinformation Open Fund” aims to support journalistic efforts to effectively fact-check misinformation about the COVID-19 immunization process, the initiative belonging to Alphabet’s Google said in a blog post.
For all the latest headlines follow our Google News channel online or via the app
“While the COVID-19 infodemic has been global in nature, misinformation has also been used to target specific populations,” it added.
“Some of the available research also suggests that the audiences coming across misinformation and those seeking fact checks don’t necessarily overlap.”
Read more: Herd immunity not possible this year, despite COVID-19 vaccine roll-out, say experts
The fund will accept projects looking to expand the audience of fact-checks, particularly to groups disproportionately hit by misinformation.
Applications will be reviewed by team of 14 jurors from across the academic, media, medical and non-profit sectors, as well as representatives from the World Health Organization.
In December, the Google News Initiative pledged $1.5 million to fund a COVID-19 vaccine media hub to support fact-checking research.
UK’s David Attenborough receives COVID-19 vaccineBritish naturalist David Attenborough, 94, has received a vaccination against ... World News
India to decide on coronavirus vaccine exports in few weeks, says foreign ministerIndia will be able to decide on exports of coronavirus vaccines within the next ... World News
Coronavirus: European Medicines Agency considering Oxford-AstraZeneca vaccineThe European Medicines Agency said AstraZeneca and Oxford University have ... Coronavirus
25.5 mln doses of COVID-19 vaccines distributed, nearly 9 mln administered: US CDCThe US Centers for Disease Control and Prevention said it had administered ... Coronavirus
Herd immunity not possible this year, despite COVID-19 vaccine roll-out, say expertsThe roll-out of coronavirus vaccines in many countries will not provide herd ... Coronavirus
Coronavirus: BioNTech lifts 2021 COVID-19 vaccine output target to 2 bln dosesPfizer’s partner BioNTech boosted the 2021 delivery target for their COVID-19 ... Coronavirus